Literature DB >> 8807255

Aspiration cytodiagnosis of a rare carcinoma of breast with bizarre malignant giant cells.

R K Gupta1.   

Abstract

On a review of our experience with 14,526 fine-needle aspiration cytology (FNAC) studies of the breast which were done from January 1983 to July 1994, five cases of the rare breast carcinoma were diagnosed in which bizarre, pleomorphic malignant giant cells formed an integral part of the tumour. In all the five cases, immunocytochemical studies were done on aspirated samples. Based on our present findings, in FNAC samples and in keeping with the findings recently described by us in a case, it is stressed that the bizarre malignant giant cells in this type of breast carcinoma are indeed of an epithelial origin. The differential diagnoses of other breast conditions in which giant cells may be seen in FNAC samples is appropriately discussed.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8807255     DOI: 10.1002/(SICI)1097-0339(199607)15:1<66::AID-DC13>3.0.CO;2-A

Source DB:  PubMed          Journal:  Diagn Cytopathol        ISSN: 1097-0339            Impact factor:   1.582


  3 in total

1.  Clinicopathologic characteristics of pleomorphic carcinoma of the breast.

Authors:  Jing Zhao; Ronggang Lang; Xiaojing Guo; Ling Chen; Feng Gu; Yu Fan; Xilin Fu; Li Fu
Journal:  Virchows Arch       Date:  2009-12-16       Impact factor: 4.064

2.  A diagnostic dilemma in breast pathology--benign fibroadenoma with multinucleated stromal giant cells.

Authors:  Helen M Heneghan; Sean T Martin; Mary Casey; Igdam Tobbia; Fadel Benani; Kevin M Barry
Journal:  Diagn Pathol       Date:  2008-08-01       Impact factor: 2.644

3.  Pleomorphic carcinoma of the breast associated with cyst formation: a unique surgical case focusing on cytological and immunohistochemical findings. Cystic breast PC.

Authors:  Sohsuke Yamada; Atsunori Nabeshima; Yoshika Nagata; Takashi Tasaki; Hirotsugu Noguchi; Shohei Kitada; Satoshi Kimura; Ke-Yong Wang; Shohei Shimajiri; Yasuyuki Sasaguri
Journal:  Diagn Pathol       Date:  2013-05-07       Impact factor: 2.644

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.